[
  {
    "ts": "2025-09-30T20:15:00+00:00",
    "headline": "Zoetis Receives Conditional Approval for Dectomax速-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle",
    "summary": "PARSIPPANY, N.J., September 30, 2025--Zoetis Inc. today announced that Dectomax速-CA1 Injectable is the first and only parasite control product to receive conditional approval from the U.S. Food and Drug Administration for the prevention and treatment of infestations caused by the larvae of Cochliomyia hominivorax (myiasis), and prevention of reinfestation for 21 days. This conditional approval applies to beef cattle, female dairy cattle less than 20 months of age, pregnant beef cows, newborn cal",
    "url": "https://finance.yahoo.com/news/zoetis-receives-conditional-approval-dectomax-201500443.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "32018832-b921-30a3-81dd-7bfb3bbe4160",
      "content": {
        "id": "32018832-b921-30a3-81dd-7bfb3bbe4160",
        "contentType": "STORY",
        "title": "Zoetis Receives Conditional Approval for Dectomax速-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle",
        "description": "",
        "summary": "PARSIPPANY, N.J., September 30, 2025--Zoetis Inc. today announced that Dectomax速-CA1 Injectable is the first and only parasite control product to receive conditional approval from the U.S. Food and Drug Administration for the prevention and treatment of infestations caused by the larvae of Cochliomyia hominivorax (myiasis), and prevention of reinfestation for 21 days. This conditional approval applies to beef cattle, female dairy cattle less than 20 months of age, pregnant beef cows, newborn cal",
        "pubDate": "2025-09-30T20:15:00Z",
        "displayTime": "2025-09-30T20:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/d4e6d3b4234c4632f7bd65b83b00f6fa",
          "originalWidth": 1035,
          "originalHeight": 387,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HNCwTWM_AKQM3a52OjW8Kw--~B/aD0zODc7dz0xMDM1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/d4e6d3b4234c4632f7bd65b83b00f6fa.cf.webp",
              "width": 1035,
              "height": 387,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KdkIEYffaJ4dyLTIxonpdA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/d4e6d3b4234c4632f7bd65b83b00f6fa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-receives-conditional-approval-dectomax-201500443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-receives-conditional-approval-dectomax-201500443.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]